Panacea Biotec Ltd
NSE:PANACEABIO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Panacea Biotec Ltd
Net Income (Common)
Panacea Biotec Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Panacea Biotec Ltd
NSE:PANACEABIO
|
Net Income (Common)
-â‚ą11.7m
|
CAGR 3-Years
80%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
|
Net Income (Common)
-â‚ą184.8m
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
Transgene Biotek Ltd
BSE:526139
|
Net Income (Common)
-â‚ą6.6m
|
CAGR 3-Years
60%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
Net Income (Common)
â‚ą83m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
Net Income (Common)
â‚ą188.9m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Biocon Ltd
NSE:BIOCON
|
Net Income (Common)
â‚ą10.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
See Also
What is Panacea Biotec Ltd's Net Income (Common)?
Net Income (Common)
-11.7m
INR
Based on the financial report for Mar 31, 2024, Panacea Biotec Ltd's Net Income (Common) amounts to -11.7m INR.
What is Panacea Biotec Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
80%
Over the last year, the Net Income (Common) growth was 96%. The average annual Net Income (Common) growth rates for Panacea Biotec Ltd have been 80% over the past three years .